9.870USD-5.50%Mkt Cap: 908.50M USDP/E: —Last update: 2026-06-01
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited ret…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap908.50M USD
Enterprise Value1.00B USD
Revenue (TTM)79.76M USD
Gross Profit76.55M USD
Net Income (TTM)-114.20M USD
Revenue/Share0.9850 USD
Last Price9.870 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees409
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINKYG596651029
Valuation
P/E (Trailing)—
P/E (Forward)-7.65
PEG—
EV/EBITDA-10.81
EV/Revenue12.57
P/S12.37
P/B-14.92
EPS (TTM)-1.48
EPS (Forward)-1.39
52W Range
5.02071% of range11.85
52W High11.85 USD
52W Low5.020 USD
Profitability
Gross Margin94.05%
Oper. Margin-13930.72%
EBITDA Margin-116.25%
Profit Margin-140.31%
ROE1971.36%
ROA-46.72%
Growth
Revenue Growth-84.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-46.36M USD
CapEx (TTM)4.24M USD
FCF Margin56.44%
FCF Yield4.95%
Net Debt15.99M USD
Net Debt/EBITDA-0.17
Balance Sheet
Debt/Equity-15.31
Current Ratio0.55
Quick Ratio0.51
Book Value/Sh-0.7140 USD
Cash/Share0.7730 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)28.25 USD
Target Range19.00 USD – 50.00 USD
# Analysts8
Ownership
Shares Out.92.61M
Float52.33M
Insiders17.80%
Institutions60.50%
Short Interest
Short Ratio5.8d
Short % Float8.32%
Short % Out.5.87%
Shares Short5.44M
Short (prev mo.)4.63M
Technical
SMA 509.252 (+6.7%)
SMA 2008.266 (+19.4%)
Beta1.24
S&P 52W Chg27.94%
Avg Vol (30d)726.08K
Avg Vol (10d)893.20K
Technical Indicators
RSI (14)62.8
MACD0.1411
MACD Signal0.1033
MACD Hist.+0.0378
BB Upper10.30 USD
BB Middle9.684 USD
BB Lower9.069 USD
BB Width12.71%
ATR (14)0.5183 USD
Vol Ratio (20d)1.04x